$189.43
-$5.72(-2.93%)
*Data last updated: 2026-07-06 17:45 (UTC+8)
As of 2026-07-06 17:45, AstraZeneca (AZN) is priced at $189.43, with a total market cap of $271.29B, a P/E ratio of 26.52, and a dividend yield of 1.79%. Today, the stock price fluctuated between $186.24 and $190.20. The current price is 1.71% above the day's low and 0.40% below the day's high, with a trading volume of 1.52M. Over the past 52 weeks, AZN has traded between $72.89 to $212.72, and the current price is -10.94% away from the 52-week high.
AZN Key Stats
Yesterday's Close$177.89
Market Cap$271.29B
Volume1.52M
P/E Ratio26.52
Dividend Yield (TTM)1.79%
Dividend Amount$2.17
Diluted EPS (TTM)6.74
Net Income (FY)$10.25B
Revenue (FY)$58.73B
Earnings Date2026-07-27
EPS Estimate2.10
Revenue Estimate$15.46B
Shares Outstanding1.52B
Beta (1Y)0.214
Ex-Dividend Date2026-02-20
Dividend Payment Date2026-03-23
About AZN
AstraZeneca PLC operates as a global biopharmaceutical leader, dedicated to the entire process of bringing prescription medicines to market, from their initial discovery and development through manufacturing and commercialization. The company's extensive portfolio of treatments, including prominent examples like Tagrisso, Farxiga, and Symbicort, addresses critical areas such as cardiovascular, renal, metabolic, and oncological conditions. Furthermore, it provides essential solutions for COVID-19 and various rare diseases, with products like Vaxzevria and Soliris. AstraZeneca engages with primary and specialty care physicians worldwide, facilitating distribution through a robust network of representatives and local offices across the United Kingdom, continental Europe, the Americas, Asia, Africa, and Australasia. The firm actively drives innovation through strategic collaborations, partnering with entities such as Neurimmune AG for the development and commercialization of NI006, BenevolentAI for systemic lupus erythematosus drug discovery, Lunit for AI-powered digital pathology risk assessment in NSCLC, and Absci Corporation for AI-driven oncology target identification. Founded in 1992, the company was initially known as Zeneca Group PLC, subsequently rebranding to AstraZeneca PLC in April 1999, and maintains its headquarters in Cambridge, United Kingdom.
SectorHealthcare
IndustryDrug Manufacturers - General
CEOPascal Claude Roland Soriot
HeadquartersCambridge,None,GB
Official Websitehttps://www.astrazeneca.com
Employees (FY)2.02K
Average Revenue (1Y)$29.03M
Net Income per Employee$5.06M
AstraZeneca (AZN) FAQ
What's the stock price of AstraZeneca (AZN) today?
x
AstraZeneca (AZN) is currently trading at $189.43, with a 24h change of -2.93%. The 52-week trading range is $72.89–$212.72.
What are the 52-week high and low prices for AstraZeneca (AZN)?
x
What is the price-to-earnings (P/E) ratio of AstraZeneca (AZN)? What does it indicate?
x
What is the market cap of AstraZeneca (AZN)?
x
What is the most recent quarterly earnings per share (EPS) for AstraZeneca (AZN)?
x
Should you buy or sell AstraZeneca (AZN) now?
x
What factors can affect the stock price of AstraZeneca (AZN)?
x
How to buy AstraZeneca (AZN) stock?
x
Risk Warning
The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.
Disclaimer
The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.